Open Access

Panel discussion - Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.

Congress Session

About the speaker

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)
57 presentations
0 follower

4 more presentations in this session

Introduction - Enabling and renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Renin-angiotensin-aldosterone system inhibitor therapy benefit and challenges in cardio-renal patients.

Speaker: Professor M. Weir (Baltimore, US)

Thumbnail

Changing the treatment paradigm of hyperkalaemia management to enable and optimise renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor S. Anker (Berlin, DE)

Thumbnail

Summary and conclusion - Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management.

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Access the full session

Enabling and optimising renin-angiotensin-aldosterone system inhibitor therapy in cardio-renal patients through hyperkalaemia management

Speakers: Professor M. Boehm, Professor M. Boehm, Professor M. Weir, Professor S. Anker, Professor M. Boehm
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk